DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Multiple Sclerosis Market and Competitive Landscape Highlights - 2016" report to their offering. The latest ...

Kesimpta is a medicine used to treat relapsing forms of multiple sclerosis (MS). Relapsing forms of MS include clinically isolated syndrome, relapsing-remitting MS, and active secondary progressive MS ...

Artificial intelligence (AI), using a simple blood test combined with standard brain images has, for the first time, been able to identify two biologically distinct types of multiple sclerosis (MS), ...

Dr Pavan Bhargava recently returned from the 2025 AAN Annual Meeting, where key updates in relapsing-remitting multiple sclerosis (RRMS) were highlighted. He noted the introduction of the 2024 ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. This enduring CE multimedia web activity is based on a ...

Multiple sclerosis (MS) is characterized by a broad array of symptoms. Despite this variability, most individuals with MS will exhibit a distinct set of symptoms during their initial clinical attack.

Levels of two types of bacteria in your gut could help improve the diagnosis and treatment of multiple sclerosis. When you purchase through links on our site, we may earn an affiliate commission. Here ...

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/n995k5/global) has announced the addition of the "Global Amyotrophic Lateral ...

Both MS and PsA are autoimmune conditions resulting from immune system dysregulation, are not contagious, and share genetic and environmental risk factors. Key links that may explain the connection ...